21-hydroxylase deficiency natural history, complications and prognosis
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency Microchapters |
Differentiating Congenital adrenal hyperplasia due to 21-hydroxylase deficiency from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
21-hydroxylase deficiency natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of 21-hydroxylase deficiency natural history, complications and prognosis |
FDA on 21-hydroxylase deficiency natural history, complications and prognosis |
CDC on 21-hydroxylase deficiency natural history, complications and prognosis |
21-hydroxylase deficiency natural history, complications and prognosis in the news |
Blogs on 21-hydroxylase deficiency natural history, complications and prognosis |
Directions to Hospitals Treating Congenital adrenal hyperplasia due to 21-hydroxylase deficiency |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]
Overview
The prognosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency is generally good with treatment. Common complications of 21-hydroxylase deficient congenital adrenal hyperplasia include short stature, adrenal crisis, infertility, and precocious puberty.
Complications
Complications associated with 21-hydroxylase deficient congenital adrenal hyperplasia include:
Prognosis
- A small percentage of children and adults with infancy or childhood onset congenital adrenal hyperplasia die of adrenal crisis. Even after diagnosis and initiation of treatment.
- Deaths from this are entirely avoidable if the child and his family understand that the daily glucocorticoids must not allow to be interrupted by an illness.
- When a person is well, missing a dose, or even several doses, may produce little in the way of immediate symptoms. However, glucocorticoid needs are increased during illness and stress.
- Missed doses during time of illness can lead within hours to hypotension, shock, and death.